CClinicalTrials.gg
CompletedNCT05341700Updated Aug 19, 2025Results posted

Impact Loading Effect on Bone Biomarkers in Female Runners

An interventional study of Impact Load Exercises and No Impact Load Exercises in Relative Energy Deficiency in Sport, sponsored by Virginia Polytechnic Institute and State University. Completed at 1 site in United States. Open to female participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-08-19.

Sponsored by Virginia Polytechnic Institute and State University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
Female
01

Study summary

This study is a randomized, cross-over intervention study that will evaluate the effect of brief, high-impact loading exercises on biomarkers of bone metabolism in energy-restricted female runners. Volunteers will complete two 5-day experimental conditions in a randomized order separated by one menstrual cycle (approximately 3 weeks). Experimental conditions will include a dietary intervention of energy intake equal to 30 kcal/kg of fat-free mass/d using controlled diets and an exercise intervention of daily treadmill running with or without an additional 50 impact loading exercises.

Read the detailed description

Many long-distance runners struggle to consume enough calories each day to match the number of calories they are burning during exercise and as part of daily living. Undereating for long periods of time is a serious concern because it can have negative effects on general health and sports performance. One of these long-term consequences is related to bone health. With undereating, bone can start to be broken down faster than it can be rebuilt. Even though it can take months, and even years, for bone to be seriously affected, this may lead to weak and brittle bones later in life, if it is left untreated. Typically, athletes are recommended to increase the number of calories they eat to prevent negative health concerns. However, not all athletes may be willing or able to increase their calories based on their performance goals, nutrition knowledge, or concerns with food security. This means that alternative strategies need to be investigated to counteract the negative effects of undereating on bone health. This study proposes to evaluate the effect of adding short bouts of high-impact jumping exercises to typical endurance training to promote healthy bone metabolism. This will specifically involve completing two phases of a supervised treadmill run and consuming a reduced-calorie diet (provided by the research team) on 5 consecutive days. In addition, one of the phases will include performing 5 sets of 10 jumping exercises on 5 consecutive days in addition to the treadmill run. Results of the study will serve as an important first step in helping exercise and medical professionals understand more about how to protect and manage the bone health of female long-distance runners.

02

Conditions studied

  • Relative Energy Deficiency in Sport

Keywords

  • Bone metabolism
  • Endurance exercise
  • Low energy availability
  • Jump training
03

In context

Relative Energy Deficiency in Sport

20 studies on the registry are indexed under Relative Energy Deficiency in Sport; 10 are open to participants now.

This study's enrollment of 14 is below the median of 50 across 11 interventional studies indexed under Relative Energy Deficiency in Sport.

Browse Relative Energy Deficiency in Sport studies →

Lead sponsor

Virginia Polytechnic Institute and State University is the lead sponsor of 124 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Females runners with regular menstrual cycles, not using contraceptives
  • Body Mass Index between 18.5-30.0 kg/m2
  • Weight stable (+/- 2 kg) for 6 months
  • VO2max of ≥35 ml/kg/min
  • Willing to consume provided meals and snacks

Exclusion criteria

Exclusion Criteria:

  • Low Energy Availability in Females Questionnaire (LEAF-Q) score ≥8
  • Menstrual disturbances measured by progesterone and self-report
  • Using contraceptives (oral contraceptives, injections, intrauterine device, etc.)
  • Low Bone Mineral Density (z-score \< -1)
  • Routine engagement in mechanical loading exercises
  • History of fracture in the previous 6 months
  • Recent recovery (within the last 12 months) or still in recovery after eating disorder diagnosis
  • Medication use that could affect bone metabolism (e.g., corticosteroids, anticonvulsants, heparin, gonadotropin-releasing hormone agonists)
  • Pregnancy or lactation
  • Abnormal thyroid-stimulating hormone levels
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
14 participants (actual)

Study arms

  • Experimental
    Endurance and Jumping Exercises

    5 days of endurance treadmill running and 5 sets of 10 jumping exercises

    Behavioral: Impact Load Exercises

  • Active comparator
    Endurance Exercise Only

    5 days of endurance treadmill running

    Behavioral: No Impact Load Exercises

Interventions

  • BehavioralImpact Load Exercises

    Participants will complete 50-65 min running protocol on treadmill and 5 sets of 10 jumping exercises for 5 consecutive days. Participants will also be provided all meals and snacks to induce a energy-restricted state for the 5-day period.

  • BehavioralNo Impact Load Exercises

    Participants will complete only a 50-65 min running protocol on treadmill for 5 consecutive days. Participants will also be provided all meals and snacks to induce a energy-restricted state for the 5-day period.

06

What researchers measure

Primary outcomes

  1. Change in Bone Remodeling Biomarker - N-terminal Propeptide of Type 1 Procollagen

    Plasma N-terminal propeptide of type 1 procollagen (PINP) was collected from fasted blood samples drawn before and after each 5-day intervention. The enzyme-linked immunosorbent assays (ELISA) were performed on all samples upon study completion.

    Time frame: 10-minute blood draw in laboratory; samples assessed on intervention day 0 and day 6

  2. Change in Bone Remodeling Biomarker - C-terminal Telopeptide of Type 1 Collagen (CTX)

    Serum C-terminal telopeptide of type 1 collagen (CTX) was collected from fasted blood samples drawn before and after each 5-day intervention. The enzyme-linked immunosorbent assays (ELISA) were performed on all samples upon study completion.

    Time frame: 10-minute blood draw in laboratory; samples assessed on intervention day 0 and day 6

  3. Change in Blood Metabolic Marker - Parathyroid Hormone

    Parathyroid hormone levels were measured from fasted blood samples collected before and after each 5-day intervention. The enzyme-linked immunosorbent assays (ELISA) were performed on all samples upon study completion.

    Time frame: 10-minute blood draw in laboratory; samples assessed on intervention day 0 and day 6

  4. Change in Blood Metabolic Marker - Insulin-like Growth Factor-1

    Insulin-like growth factor-1 (IGF1) concentration was measured from fasted blood samples collected before and after each 5-day intervention. The enzyme-linked immunosorbent assays (ELISA) were performed on all samples upon study completion.

    Time frame: 10-minute blood draw in laboratory; samples assessed on intervention day 0 and day 6

Secondary outcomes

  1. Change in Ferritin

    Fasted serum ferritin was measured before and after each 5-day intervention period.

    Time frame: 10-minute blood draw in laboratory; samples assessed on intervention day 0 and day 6

07

Results

Posted Aug 19, 2025

Participant flow

38 individuals were screened for eligibility between August 2, 2022 and October 13, 2023 in Southwest Virginia.

First Intervention (5 Days)
Participant flow — First Intervention (5 Days)
MilestoneRUN, Then RUN+JRUN+J, Then RUN
Started77
Completed67
Not completed10
Washout (One Menstrual Cycle, ~21 Days)
Participant flow — Washout (One Menstrual Cycle, ~21 Days)
MilestoneRUN, Then RUN+JRUN+J, Then RUN
Started67
Completed65
Not completed02
Second Intervention (5 Days)
Participant flow — Second Intervention (5 Days)
MilestoneRUN, Then RUN+JRUN+J, Then RUN
Started65
Completed55
Not completed10

Outcome measures

PrimaryChange in Bone Remodeling Biomarker - N-terminal Propeptide of Type 1 Procollagen

Plasma N-terminal propeptide of type 1 procollagen (PINP) was collected from fasted blood samples drawn before and after each 5-day intervention. The enzyme-linked immunosorbent assays (ELISA) were performed on all samples upon study completion.

Time frame:
10-minute blood draw in laboratory; samples assessed on intervention day 0 and day 6
Reported as:
Mean · ng/mL
Change in Bone Remodeling Biomarker - N-terminal Propeptide of Type 1 Procollagen
ng/mLEndurance and Jumping Exercises (RUN+J)Endurance Exercise Only (RUN)
Change in Bone Remodeling Biomarker - N-terminal Propeptide of Type 1 Procollagen-3.1 ± 5.71.1 ± 7.2
Statistical analysis
  • Endurance and Jumping Exercises (RUN+J) vs Endurance Exercise Only (RUN) · Mixed Models Analysis · p = 0.246
PrimaryChange in Bone Remodeling Biomarker - C-terminal Telopeptide of Type 1 Collagen (CTX)

Serum C-terminal telopeptide of type 1 collagen (CTX) was collected from fasted blood samples drawn before and after each 5-day intervention. The enzyme-linked immunosorbent assays (ELISA) were performed on all samples upon study completion.

Time frame:
10-minute blood draw in laboratory; samples assessed on intervention day 0 and day 6
Reported as:
Mean · ng/mL
Change in Bone Remodeling Biomarker - C-terminal Telopeptide of Type 1 Collagen (CTX)
ng/mLEndurance and Jumping Exercises (RUN+J)Endurance Exercise Only (RUN)
Change in Bone Remodeling Biomarker - C-terminal Telopeptide of Type 1 Collagen (CTX)0.04 ± 0.090.04 ± 0.12
Statistical analysis
  • Endurance and Jumping Exercises (RUN+J) vs Endurance Exercise Only (RUN) · Mixed Models Analysis · p = 0.714
PrimaryChange in Blood Metabolic Marker - Parathyroid Hormone

Parathyroid hormone levels were measured from fasted blood samples collected before and after each 5-day intervention. The enzyme-linked immunosorbent assays (ELISA) were performed on all samples upon study completion.

Time frame:
10-minute blood draw in laboratory; samples assessed on intervention day 0 and day 6
Reported as:
Mean · pg/mL
Change in Blood Metabolic Marker - Parathyroid Hormone
pg/mLEndurance and Jumping Exercises (RUN+J)Endurance Exercise Only (RUN)
Change in Blood Metabolic Marker - Parathyroid Hormone3.3 ± 6.1-1.0 ± 11.8
Statistical analysis
  • Endurance and Jumping Exercises (RUN+J) vs Endurance Exercise Only (RUN) · Mixed Models Analysis · p = 0.309
PrimaryChange in Blood Metabolic Marker - Insulin-like Growth Factor-1

Insulin-like growth factor-1 (IGF1) concentration was measured from fasted blood samples collected before and after each 5-day intervention. The enzyme-linked immunosorbent assays (ELISA) were performed on all samples upon study completion.

Time frame:
10-minute blood draw in laboratory; samples assessed on intervention day 0 and day 6
Reported as:
Mean · ng/mL
Change in Blood Metabolic Marker - Insulin-like Growth Factor-1
ng/mLEndurance and Jumping Exercises (RUN+J)Endurance Exercise Only (RUN)
Change in Blood Metabolic Marker - Insulin-like Growth Factor-1-11.4 ± 10.3-8.0 ± 6.3
Statistical analysis
  • Endurance and Jumping Exercises (RUN+J) vs Endurance Exercise Only (RUN) · Mixed Models Analysis · p = 0.308
SecondaryChange in Ferritin

Fasted serum ferritin was measured before and after each 5-day intervention period.

Time frame:
10-minute blood draw in laboratory; samples assessed on intervention day 0 and day 6
Reported as:
Mean · ng/mL
Change in Ferritin
ng/mLEndurance and Jumping Exercises (RUN+J)Endurance Exercise Only (RUN)
Change in Ferritin4.1 ± 11.311.4 ± 11.5
Statistical analysis
  • Endurance and Jumping Exercises (RUN+J) vs Endurance Exercise Only (RUN) · Mixed Models Analysis · p = 0.207

Adverse events

Collected over One week for each intervention.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Endurance and Jumping Exercise (RUN+J)0/12 (0%)0/12 (0%)0/12 (0%)
Endurance Exercise Only (RUN)0/10 (0%)0/10 (0%)0/10 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(Years)RUN, Then RUN+JRUN+J, Then RUNTotal
Mean25.3 ± 4.226.9 ± 3.626.2 ± 3.8
Sex: Female, Male
Sex: Female, Male(Participants)RUN, Then RUN+JRUN+J, Then RUNTotal
Female6713
Male000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)RUN, Then RUN+JRUN+J, Then RUNTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American112
White5510
More than one race011
Unknown or Not Reported000
08

Study locations

1 site
  • Virginia Polytechnic Institute and State University
    Blacksburg, Virginia 24061, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Sep 11, 2023

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05341700
Lead sponsor
Virginia Polytechnic Institute and State University
Responsible party
Dawnine Enette Larson-Meyer (Professor, Virginia Polytechnic Institute and State University) — Principal investigator
First posted
Apr 22, 2022
Start date
Aug 24, 2022
Primary completion
Jan 23, 2024
Completion
Apr 12, 2024
Results posted
Aug 19, 2025
Last update
Aug 19, 2025

Study contacts

Enette Larson-Meyer, PhD
principal investigator · Virginia Polytechnic Institute and State University (Virginia Tech)

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion